Catherine S. Kim, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Medicine | Virtua Radiation Oncology - Voorhees
View 1 additional location
Make an appointmentCall 800-789-7366
Headshot of Catherine S. Kim, MD
Penn Medicine Provider

About me

  • Medical Director, Penn Medicine Virtua Moorestown, Radiation Oncology
  • Medical Director, Penn Medicine Virtua Voorhees, Radiation Oncology
  • Regional Network Medical Director, Radiation Oncology

My education and training

  • Medical School: Thomas Jefferson University
  • Residency: Mount Sinai Morningside
  • Residency: Thomas Jefferson University Hospital

Spoken languages

English
English
한국어
Korean

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kim is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

Research

Publications

Kim CS, Jeter MD Radiation Therapy, Early Stage Non-Small Cell Lung Cancer , www.statpearls.com (Academic eLearning Management System): 2017

Kim CS, Algan O Radiation Therapy, Early Stage Breast Cancer , www.statpearls.com (Academic eLearning Management System): 2017

Amsbaugh M, Kim CS Brain Metastases , www.statpearls.com (Academic eLearning Management System): 2016

Kim Catherine S, Werner-Wasik Maria Images in clinical medicine. Lymphadenopathy. , N Engl J Med, 359(15): 2008,1602

Kim CS, Anne PR, Mitchell EP, Palazzo J, Pequignot E, Fishel R, Goldstein SD, Isenberg GA, Curran W Impact of Pretreatment Tumor Size and Lymph Nodes on Pathologic Complete Response and Survival in a Prospective Trial of Chemoradiation for Locally Advanced Local Rectal Cancer , Int J Radiat Oncol Biol Phys , 63(1): 2005,S164-S165

Kim CS, Anne PR, Mitchell EP, Palazzo J, Pequignot E, Fishel R, Goldstein SD, Isenberg GA, Curran W Tumor size as a predictor of pathologic complete response (pCR) and survival in a prospective trial of chemoradiation for locally advanced rectal cancer , Proc Am Soc Clin Onco, 23(16S): 2005

Kim CS, Gumbs AA, Komarnicky L, Carter D, Hutter R, Palazzo JP, McCure PA, Goodman R, Haffty BG, Rebbeck TR, Weber BL, Turner BC Predicted Gremline BRCA/IBRCA2 Mutations and Second Primary Ipsilateral Breast Cancers in Young Women with Pure Ductal Carinoma in-situ Treated with Breast Conserving Therapy , Int J Radiat Oncol Biol Phys, 48(3, Supplement 1): 2000,142-143